Evaluation of Survival and Postoperative Radiation Among Patients with Advanced Medullary Thyroid Carcinoma: An Analysis of the National Cancer Database

被引:6
作者
Ow, Thomas J. [1 ,2 ]
Mehta, Vikas [1 ]
Kim, Seokhwa [3 ]
Vakil, Mayand [4 ]
Friedmann, Patricia [5 ,6 ]
In, Haejin [5 ,7 ,8 ]
机构
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA
[3] Hana ENT Hosp, Gangdong Hana ENT Clin, Seoul, South Korea
[4] Rutgers New Jersey Med Sch, Dept Otolaryngol Head & Neck Surg, Newark, NJ USA
[5] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Surg, Bronx, NY 10467 USA
[6] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Cardiothorac & Vasc Surg, Bronx, NY 10467 USA
[7] Rutgers Canc Inst New Jersey, Div Surg Oncol, New Brunswick, NJ USA
[8] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA
关键词
NECK-CANCER; HEAD; RADIOTHERAPY; MANAGEMENT; TOXICITY; THERAPY; STROKE; RISK;
D O I
10.1245/s10434-021-11158-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background This study compared survival between patients who had medullary thyroid cancer (MTC) treated with surgery alone and patients who underwent surgery and radiation (SRT). Methods Patients from the National Cancer Database (NCDB) with a diagnosis of stage 3 or 4 MTC, lymph node disease, and no distant metastases between 2008 and 2016 were studied. Kaplan-Meier analyses and log-rank statistics were used to estimate and compare overall survival between patients treated with surgery alone and those treated with SRT. Mutlivariable Cox proportional hazards models and propensity-matching were used to adjust for confounding and selection bias. Results Among 1370 patients, 1112 (81%) received surgery alone, and 258 (19%) received SRT. The hazard ratio for mortality in the SRT group was 1.784 (95% confidence interval [CI] 1.313-2.43) after multivariable adjustment for confounding variables. Furthermore, SRT remained associated with a higher mortality rate (p < 0.008) after propensity-matching in an effort to adjust for selection bias. Conclusions This analysis of NCDB patients showed that SRT is associated with a significantly higher mortality rate among patients treated for stage 3 or 4 IV MTC with positive lymph node disease. Although this observation can be attributed to unmeasured confounders or selection bias, the cause for the profound survival differences deserves prospective evaluation, especially as adjuvant therapies for this disease continue to evolve.
引用
收藏
页码:2582 / 2591
页数:10
相关论文
共 26 条
[1]   Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer [J].
Adam, Mohamed Abdelgadir ;
Thomas, Samantha ;
Roman, Sanziana A. ;
Hyslop, Terry ;
Sosa, Julie A. .
JAMA SURGERY, 2017, 152 (09) :869-876
[2]   Stroke After Radiation Therapy for Head and Neck Cancer: What Is the Risk? [J].
Arthurs, Erin ;
Hanna, Timothy P. ;
Zaza, Khaled ;
Peng, Yingwei ;
Hall, Stephen F. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (03) :589-596
[3]   Medullary thyroid cancer: Analyses of survival and prognostic factors and the role of radiation therapy in local control [J].
Brierley, J ;
Tsang, R ;
Simpson, WJ ;
Gospodarowicz, M ;
Sutcliffe, S ;
Panzarella, T .
THYROID, 1996, 6 (04) :305-310
[4]   A role for radiotherapy in the management of advanced medullary thyroid carcinoma: the Mayo Clinic experience [J].
Call, Jason A. ;
Caudill, Jonathan S. ;
McIver, Bryan ;
Foote, Robert L. .
RARE TUMORS, 2013, 5 (03) :128-131
[5]   The risk of carotid stenosis in head and neck cancer patients after radiation therapy [J].
Carpenter, David J. ;
Mowery, Yvonne M. ;
Broadwater, Gloria ;
Rodrigues, Anna ;
Wisdom, Amy J. ;
Dorth, Jennifer A. ;
Patel, Pretesh R. ;
Shortell, Cynthia K. ;
Clough, Robert ;
Brizel, David M. .
ORAL ONCOLOGY, 2018, 80 :9-15
[6]   Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years [J].
Dorresteijn, LDA ;
Kappelle, AC ;
Boogerd, W ;
Klokman, WJ ;
Balm, AJM ;
Keus, RB ;
van Leeuwen, FE ;
Bartelink, H .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :282-288
[7]   Medullary thyroid cancer: The role of radiotherapy in local control [J].
Fife, KM ;
Bower, M ;
Harmer, CL .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (06) :588-591
[8]   Multikinase inhibitors in thyroid cancer: timing of targeted therapy [J].
Gild, Matti L. ;
Tsang, Venessa H. M. ;
Clifton-Bligh, Roderick J. ;
Robinson, Bruce G. .
NATURE REVIEWS ENDOCRINOLOGY, 2021, 17 (04) :225-234
[9]   Radiation-induced carotid artery atherosclerosis [J].
Gujral, Dorothy M. ;
Chahal, Navtej ;
Senior, Roxy ;
Harrington, Kevin J. ;
Nutting, Christopher M. .
RADIOTHERAPY AND ONCOLOGY, 2014, 110 (01) :31-38
[10]   NCCN Guidelines® Insights Thyroid Carcinoma, Version 2.2018 Featured Updates to the NCCN Guidelines [J].
Haddad, Robert I. ;
Nasr, Christian ;
Bischoff, Lindsay ;
Busaidy, Naifa Lamki ;
Byrd, David ;
Callender, Glenda ;
Dickson, Paxton ;
Duh, Quan-Yang ;
Ehya, Hormoz ;
Goldner, Whitney ;
Haymart, Megan ;
Hoh, Carl ;
Hunt, Jason P. ;
Iagaru, Andrei ;
Kandeel, Fouad ;
Kopp, Peter ;
Lamonica, Dominick M. ;
McIver, Bryan ;
Raeburn, Christopher D. ;
Ridge, John A. ;
Ringel, Matthew D. ;
Scheri, Randall P. ;
Shah, Jatin P. ;
Sippel, Rebecca ;
Smallridge, Robert C. ;
Sturgeon, Cord ;
Wang, Thomas N. ;
Wirth, Lori J. ;
Wong, Richard J. ;
Johnson-Chilla, Alyse ;
Hoffmann, Karin G. ;
Gurski, Lisa A. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (12) :1429-1440